These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 22151795)
1. Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles. Yang J; Sun H; Song C Diabetes Obes Metab; 2012 Apr; 14(4):358-64. PubMed ID: 22151795 [TBL] [Abstract][Full Text] [Related]
2. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin. Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666 [TBL] [Abstract][Full Text] [Related]
3. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation. Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168 [TBL] [Abstract][Full Text] [Related]
4. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Jain S; Rathi VV; Jain AK; Das M; Godugu C Nanomedicine (Lond); 2012 Sep; 7(9):1311-37. PubMed ID: 22583576 [TBL] [Abstract][Full Text] [Related]
5. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles. Kumar PS; Ramakrishna S; Saini TR; Diwan PV Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069 [TBL] [Abstract][Full Text] [Related]
6. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761 [TBL] [Abstract][Full Text] [Related]
7. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles. Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208 [TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles. Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439 [TBL] [Abstract][Full Text] [Related]
9. [Study on preparation and oral efficacy of insulin-loaded poly(lactic-co-glycolic acid) nanoparticles]. Pan Y; Xu H; Zhao HY; Wei G; Zheng JM Yao Xue Xue Bao; 2002 May; 37(5):374-7. PubMed ID: 12579845 [TBL] [Abstract][Full Text] [Related]
10. Hydrophilic poly (ethylene glycol) capped poly (lactic-co-glycolic) acid nanoparticles for subcutaneous delivery of insulin in diabetic rats. S S; S M; P S L S; S S; S B; V P Int J Biol Macromol; 2017 Feb; 95():1190-1198. PubMed ID: 27825822 [TBL] [Abstract][Full Text] [Related]
11. Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: development, pharmacokinetics, biodistribution and pharmacodynamics. Sharma G; van der Walle CF; Ravi Kumar MN Int J Pharm; 2013 Jan; 440(1):99-110. PubMed ID: 22227604 [TBL] [Abstract][Full Text] [Related]
12. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation. Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443 [TBL] [Abstract][Full Text] [Related]
13. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery. Xiong XY; Li YP; Li ZL; Zhou CL; Tam KC; Liu ZY; Xie GX J Control Release; 2007 Jul; 120(1-2):11-7. PubMed ID: 17509718 [TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery. Sheshala R; Peh KK; Darwis Y Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637 [TBL] [Abstract][Full Text] [Related]
15. Novel PLGA-based nanoparticles for the oral delivery of insulin. Malathi S; Nandhakumar P; Pandiyan V; Webster TJ; Balasubramanian S Int J Nanomedicine; 2015; 10():2207-18. PubMed ID: 25848248 [TBL] [Abstract][Full Text] [Related]
16. Multi-arm histidine copolymer for controlled release of insulin from poly(lactide-co-glycolide) microsphere. Park W; Kim D; Kang HC; Bae YH; Na K Biomaterials; 2012 Dec; 33(34):8848-57. PubMed ID: 22959184 [TBL] [Abstract][Full Text] [Related]
17. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Makhlof A; Tozuka Y; Takeuchi H Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Hassanzadeh K; Mahdavi H; Koohsoltani M; Nokhodchi A Biopharm Drug Dispos; 2010 Mar; 31(2-3):189-201. PubMed ID: 20238376 [TBL] [Abstract][Full Text] [Related]
19. Investigation of drug loading and in vitro release mechanisms of insulin-lauryl sulfate complex loaded PLGA nanoparticles. Shi K; Cui F; Yamamoto H; Kawashima Y Pharmazie; 2008 Dec; 63(12):866-71. PubMed ID: 19177901 [TBL] [Abstract][Full Text] [Related]
20. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats. Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]